FIELD: chemistry.
SUBSTANCE: invention relates to C-phenyl-1-thioglucitols of formula (I), [formula I] , where X is a hydrogen atom or a C1-6alkyl group, Y is a C1-6alkylene group or -O-(CH2)n- (where n equals a integer from 1 to 5), and Z is -CONHRA or -NHCONHRB (provided that when Z is -NHCONHRB, n is not equal to 1), where RA is a C1-6alkyl group substituted with 1-3 substitutes selected from a group consisting of a hydroxyl group and -CONH2, and RB denotes a hydrogen atom or a C1-6alkyl group substituted with 1-3 substitutes selected from a group consisting of a hydroxyl group and -CONH2, and pharmaceutically acceptable salts thereof or hydrates thereof. The invention also relates to a sodium-dependent glucose transporter 1 (SGLT1) activity inhibitor, a sodium-dependent glucose transporter 1 (SGLT1) and sodium-dependent glucose transporter 2 (SGLT2) activity inhibitor, as well as a prophylactic or therapeutic agent against diabetes.
EFFECT: obtaining novel biologically active compounds which are sodium-dependent glucose transporter 1 and sodium-dependent glucose transporter 2 activity inhibitors.
5 cl, 11 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
1-THIO-D-GLUCITOL DERIVATIVES | 2006 |
|
RU2387649C2 |
AZULENE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF DIABETES MELLITUS | 2003 |
|
RU2295522C2 |
SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
C-GLYCOSIDE DERIVATIVES AND THEIR SALTS | 2004 |
|
RU2317288C2 |
PROPHYLACTIC OR THERAPEUTIC DRUG FOR CONSTRUCTION | 2014 |
|
RU2648467C2 |
PYRAZOLE DERIVATIEVES, MEDICAL COMPOSITIONS, CONTAINING SAID DERIVATIVES, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR OBTAINING | 2003 |
|
RU2356906C2 |
PYRAZOL DERIVATIVES, MEDICAL COMPOSITIONS, CONTAINING THEM, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR PRODUCTION | 2003 |
|
RU2369613C2 |
NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG AND SALT THEREOF AND DIABETES THERAPEUTIC AGENT CONTAINING SAID COMPOUNDS | 2005 |
|
RU2394015C2 |
DERIVATIVES OF ARYL-5-THIO-β-D-GLYCOPYRANOSIDE AND THERAPEUTIC AGENT COMPRISING THEREOF USED IN DIABETES MELLITUS | 2003 |
|
RU2322449C2 |
Authors
Dates
2011-11-27—Published
2007-06-28—Filed